Germany's Gene Editing Technology Market Analysis & Forecast 2023-2027: A $378.3 Million Market by 2027
/PRNewswire/ -- The "Germany Gene Editing Technology Business and Investment Opportunities Databook - Q1 2023 Update" report has been added to...
Stay updated with breaking news from Cell Lines. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- The "Germany Gene Editing Technology Business and Investment Opportunities Databook - Q1 2023 Update" report has been added to...
Dublin, June 29, 2023 (GLOBE NEWSWIRE) -- The "Cell based Assays Market by Product & Service (Reagents, Assays Kits, Cell Lines, Microplates, Probes...
Catalent is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics, consumer health products and global clinical supply services. With over 80 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply.
Dublin, May 31, 2023 (GLOBE NEWSWIRE) -- The "Global Biobanking Market by Product & Service (Equipment, Consumable, Services, Software), Sample Type...
Cytiva and the life sciences business of Pall Corporation are now united as one business under the Cytiva brand, with the completion of the integration announced this morning. Emmanuel Ligner, Danaher Group Executive, President and CEO of Cytiva, tells us how the company will focus its efforts moving forward to support long-term growth of the biotech industry.